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AbstractöK2-Adrenergic receptors play an essential role in regulating neurotransmitter release from sympathetic nerves
and from adrenergic neurons in the CNS. However, the role of each of the three highly homologous K2-adrenergic
receptor subtypes (K2A, K2B, K2C) in this process has not been determined unequivocally. To address this question, the
regulation of norepinephrine and dopamine release was studied in mice carrying deletions in the genes encoding the three
K2-adrenergic receptor subtypes. Autoradiography and radioligand binding studies showed that K2-receptor density in
K2A-de¢cient brains was decreased to 9 þ 1% of the respective wild-type value, whereas K2-receptor levels were reduced to
83 þ 4% in K2C-de¢cient mice. These results indicate that approximately 90% of mouse brain K2-receptors belong to the
K2A subtype and 10% are K2C-receptors. In isolated brain cortex slices from wild-type mice a non-subtype-selective
K2-receptor agonist inhibited release of [3H]norepinephrine by maximally 96%. Similarly, release of [3H]dopamine
from isolated basal ganglion slices was inhibited by 76% by an K2-receptor agonist. In K2A-receptor-de¢cient mice, the
inhibitory e¡ect of the K2-receptor agonist on norepinephrine and dopamine release was signi¢cantly reduced but not
abolished. Only in tissues from mice lacking both K2A- and K2C-receptors was no K2-receptor agonist e¡ect on transmitter
release observed. The time course of onset of presynaptic inhibition of norepinephrine release was much faster for the
K2A-receptor than for the K2C-subtype. After prolonged stimulation with norepinephrine, presynaptic K2C-adrenergic
receptors were desensitized.
From these data we suggest that two functionally distinct K2-adrenergic receptor subtypes, K2A and K2C, operate as
presynaptic inhibitory receptors regulating neurotransmitter release in the mouse CNS. ß 2002 IBRO. Published by
Elsevier Science Ltd. All rights reserved.
Key words: adrenergic receptors, presynaptic receptor, dopamine, norepinephrine, transgenic mouse.
Presynaptic receptors are essential regulators of signal
transmission in the nervous system. These receptors are
located in the presynaptic membrane in close proximity
to the neurotransmitter release site and they are activated
by transmitter which has been released into the synaptic
cleft. Receptors which are located presynaptically and
modulate the release of their own neurotransmitter are
termed autoreceptors, those which regulate release of
other transmitters are heteroreceptors (Starke et al.,
1989). Within the adrenergic system, presynaptic L-recep-
tors enhance norepinephrine release while K2-receptors
inhibit further transmitter exocytosis (Starke et al.,
1989). Molecular cloning has led to the identi¢cation of
three independent genes encoding K2-adrenergic receptor
subtypes, termed K2A, K2B, and K2C (Ru¡olo et al., 1993).
As the available pharmacological ligands lack su⁄cient
subtype selectivity, it has been di⁄cult to assign unequiv-
ocally biological functions to individual K2-adrenergic
receptor subtypes. As an alternative to using pharmaco-
logical ligands, molecular genetic techniques have been
used to inactivate or modify the genes of the K2-receptor
subtypes in embryonic stem cells from which mouse lines
were established which are de¢cient in individual K2-
receptor subtypes (Link et al., 1995, 1996; MacMillan
et al., 1996; Altman et al., 1999). These mice have
recently been successfully used to assign speci¢c func-
tions of non-selective K2-receptor agonists to individual
K2-receptor subtypes (for reviews, see MacDonald and
Scheinin, 1995; Hein, 2001).
In mice lacking the K2A-receptor, presynaptic autoin-
hibition by endogenous norepinephrine or K2-receptor
agonists was signi¢cantly blunted but not abolished
(Altman et al., 1999). In sympathetic neurons, two
K2-receptors, K2A and K2C, were found to inhibit release
of norepinephrine (Hein et al., 1999). These data leave
open four major questions. First, whether K2C-receptors
are up-regulated in mice lacking K2A-receptors or
whether they are co-expressed with K2A-receptors in
wild-type mice. The second question is whether also
in the CNS the same receptors serve as inhibitory K2-
autoreceptors and third, whether the release of other
transmitters by K2-heteroreceptors follows the same prin-
ciples. Finally, we set out to determine whether presyn-
aptic K2-adrenergic receptor subtypes can be functionally
distinguished.
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EXPERIMENTAL PROCEDURES
Transgenic mouse lines lacking K2-receptor subtypes
For this study mice carrying targeted deletions of the genes
encoding K2A-, K2B-, or K2C-adrenergic receptors (K2-KO) were
used. The generation of K2B-KO and K2C-KO mice has been
described previously (Link et al., 1995, 1996). Mice lacking the
K2A-receptor subtype have been generated recently (Altman et
al., 1999). Mice carrying deletions in K2A- and K2C-receptor
genes were generated by crossing single-knockout strains (Hein
et al., 1999). Independent lines of homozygous knockout mice
and matching wild-type strains were maintained in a speci¢ed
pathogen-free facility. Genotyping was performed by Southern
blot analysis with gene probes which are external to the respec-
tive targeting vectors. For experiments, mice at 4^6 months of
age were used. All experiments were conducted in accordance
with the guidelines for the care and use of animals approved by
the University of Wu«rzburg and the responsible government
authorities (Regierung von Unterfranken, State of Bavaria).
All e¡orts were made to minimize animal su¡ering and to use
only the number of animals necessary to produce reliable data.
Autoradiography and radioligand binding
Mouse brain synaptosomes were prepared as described (Nagy
et al., 1976). Synaptosomes were resuspended in binding bu¡er
containing 25 mM glycylglycine, 40 mM HEPES (pH 8), 5 mM
EGTA, 5 mM EDTA, 5 mM MgCl2, 100 mM NaCl, 8 nM
[3H](1,4-benzodioxan-2-methoxy-2-yl)2-imidazoline hydrochlor-
ide (RX821002) (MacMillan et al., 1996). Non-speci¢c binding
was determined in the presence of 1 WM atipamezole. Receptor
autoradiography was performed in brains from 4-month-old
mice. Brains were frozen in isopentane cooled to 340‡C with
liquid nitrogen, and stored at 380‡C. Transverse sections (10
Wm) were serially cut with a cryostat, thaw-mounted onto slides
and incubated for 60 min in 50 mM Tris^HCl (pH 7.5), 1.5 mM
EDTA, 8 nM [3H]RX821002. To detect non-speci¢c binding,
1 WM atipamezole was included. Incubations were carried out
in quadruplicate. Following incubations, the slides were washed
2U5 min in cold bu¡er, rinsed in distilled water, air-dried, and
exposed to 3H-Hyper¢lm (Amersham Pharmacia, Freiburg,
Germany) for 18 weeks.
[3H]Norepinephrine release
[3H]Norepinephrine release of brain cortex was determined as
described previously with minor modi¢cations (Limberger et al.,
1995; Altman et al., 1999; Trendelenburg et al., 2001). In brief,
round brain cortex slices (2 mm diameter) were incubated with
0.1 WM [3H]norepinephrine (Amersham Pharmacia) in physio-
logical bu¡er for 30 min. Tissue pieces were then superfused for
60 min with [3H]norepinephrine-free medium containing 1 WM
desipramine at 1.8 ml/min. The superfusion medium contained
the following components (mM): NaCl 118, KCl 4.7, CaCl2 1.3,
MgSO4 1.2, NaHCO3 25, KH2PO4 1.2, glucose 11, ascorbic acid
0.57, disodium EDTA 0.03. Transmitter release was elicited by
rectangular electrical pulses of 2 ms duration and 20 V/cm volt-
age, giving a current strength of 60 mA. There were six periods
of stimulation in each experiment with intervals of 20 min. For
experiments with exogenous agonists (5-bromo-N-(4,5-dihydro-
1H-imidazol-2-yl)-6-quinoxalinamine [UK14,304] or norepi-
nephrine; Fig. 1), tissues were stimulated with single trains of
four pulses at 100 Hz. To mimic autoinhibition conditions
(Fig. 2), each stimulation period consisted of either one, two
or 64 trains (train interval 1 s) of four pulses at 100 Hz. In
order to inhibit remaining presynaptic K2-adrenergic receptors
and to determine the degree of endogenous autoinhibition, the
K2-receptor antagonist rauwolscine (1 WM) was added to the
superfusion medium 10 min before an electrical stimulation
period. The results obtained with rauwolscine in wild-type speci-
mens were identical to those obtained with the K2-receptor
antagonist atipamezole. For determination of the time course
of onset of presynaptic inhibition, release was elicited with one
to 31 rectangular pulses at 1 Hz or 3 Hz (Fig. 5). Drugs were
added to the superfusion media 15 min before electrical stimu-
lation.
For desensitization experiments, mouse atria were incubated
with [3H]norepinephrine in the presence of 1 WM rauwolscine (to
avoid activation of presynaptic K2-receptors during the loading
period). Subsequently, atria were transferred to the superfusion
chamber and superfused for 30 min with physiological bu¡er
without or with 10 WM norepinephrine. Fifteen minutes after
treatment with norepinephrine, 1 WM UK14,304 was added
to the superfusion to inhibit electrically induced release of
[3H]norepinephrine. At the end of the experiments, tissues
were processed as described below.
[3H]Dopamine release
[3H]Dopamine release of basal ganglia was determined similar
to the [3H]norepinephrine release. Basal ganglia were punched
out from frontal sections of the mouse brain (Mayer et al.,
1988). Tissue slices were preincubated for 60 min at 37‡C in
1 ml medium containing 0.3 WM of [3H]dopamine (Amersham
Pharmacia). Slices were then placed in a superfusion chamber
(t = 0 min) and superfused for 60 min with tritium-free medium
containing 1 WM nomifensine at a rate of 1 ml/min. There were
eight periods of electrical stimulation. Stimulation consisted of
rectangular pulses of 2 ms width and 30 V/cm voltage drop
between the electrodes of each chamber. The ¢rst two stimula-
tion periods at t = 20 min and t = 40 min with 20 pulses at 10 Hz
were not used for determination of tritium over£ow. The sub-
sequent stimulation periods consisted of 20 pulses at 10 Hz for
the UK14,304 experiment and of ¢ve, 10 or 50 pulses at 20 Hz
for the determination of endogenous inhibition by released
transmitter. Drugs were added 20 min before stimulation peri-
ods. At the end of [3H]norepinephrine and [3H]dopamine release
experiments, tissues were solubilized and tritium was determined
in superfusate samples and tissues. Electrically evoked over£ow
of total tritiated compounds was calculated as di¡erence
between total tritium out£ow and basal out£ow and was
expressed as a percentage of tissue tritium at the time of stim-
ulation.
Drugs
Rauwolscine HCl, desipramine HCl, nomifensine maleate and
UK14,304 were purchased from RBI/Sigma (Deisenhofen, Ger-
many). RX821002 was purchased from Amersham Pharmacia.
Atipamezole was provided by Orion (Espoo, Finland).
Statistical analysis
Data displayed show means þ S.E.M. For all experiments,
one-way or two-way analysis of variance tests followed by
appropriate post-hoc tests or t-tests were used to determine sta-
tistical signi¢cance (P6 0.05) using Prism 2.0 software (Graph-
Pad, San Diego, CA, USA).
RESULTS
Expression of K2-adrenergic receptor subtypes
In order to determine the localization and density of
brain K2-adrenergic receptors, autoradiography and
radioligand binding experiments were performed
(Fig. 1). In frontal sections from wild-type brains,
K2-adrenergic receptors were primarily detected in the
brain cortex and in the hippocampus (Fig. 1A). Signal
intensity was slightly reduced in sections from mice lack-
ing K2C-receptors and was greatly decreased in K2A-KO
brains. Only in sections from mice lacking both K2A- and
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K2C-receptors, no signal above background could be
identi¢ed (Fig. 1A). Similar results were obtained with
[3H]RX821002 binding in synaptosomes prepared from
mouse brains (Fig. 1B). K2-Receptor density in K2A-de¢-
cient brains was decreased to 9 þ 1% of the respective
wild-type value, whereas K2-receptor levels were reduced
to 83 þ 4% in K2C-de¢cient mice. These results indicate
that approximately 90% of mouse brain K2-receptors
belong to the K2A-receptor subtype and 10% are K2C-
receptors. Most importantly, K2C-receptors are expressed
in the wild-type brain and are not only up-regulated in
knockout mice lacking K2A-receptors.
Norepinephrine release from brain cortex
Small pieces of the parieto-occipital cortex were used
to examine the presynaptic regulation of norepinephrine
release in wild-type and K2-receptor-de¢cient mice. Elec-
trical stimulation by single trains of four pulses at 100
Hz elicited release of [3H]norepinephrine (Fig. 2) which
was similar in wild-type and K2-receptor-de¢cient tissues.
Under these conditions, the K2-receptor antagonist rau-
wolscine (1 WM) did not increase [3H]norepinephrine
release, because the single-pulse trains are too short for
signi¢cant autoinhibition to develop (Marshall, 1983;
Singer, 1988). In wild-type brain cortex, the K2-agonist
UK14,304 caused concentration-dependent inhibition of
the norepinephrine release by maximally 96% (Fig. 2A,
B). In mice lacking K2B- or K2C-receptors, the e¡ect of
the K2-receptor agonist was not di¡erent from wild-type
mice. However, in K2A-de¢cient cortex UK14,304 inhib-
ited transmitter release by 24% (Fig. 2B). Thus the
K2A-receptor is the principal autoreceptor regulating nor-
epinephrine release in the brain cortex as has been sug-
gested previously from pharmacological experiments
(Limberger et al., 1995). In order to determine which
Fig. 1. Expression of K2-adrenergic receptor subtypes in the brain of K2-KO mice. (A) Autoradiograms of [3H]RX821002
speci¢c binding in the brain of wild-type (WT) and K2-receptor knockout mice. In wild-type mouse brain, highest levels of
K2-receptors were expressed in brain cortex and hippocampus. In the presence of the K2-receptor antagonist atipamezole, the
signal was reduced to the background level (data not shown). (B) K2-Adrenergic receptor density in mouse brain synapto-
somes. Total K2-receptor binding was determined in synaptosomes in the presence of 8 nM RX821002 (fmol/mg membrane
protein). For non-speci¢c binding, 1 WM atipamezole was used. In synaptosomes from K2A-KO mice, K2-receptor density was
decreased by 90%, whereas in mice lacking K2C-receptors, a 17% reduction in receptor levels was found. Only in specimens
from K2AC-KO mice, no speci¢c K2-receptor binding could be detected. Data shown are representative autoradiograms from
three experiments with slices slices per genotype and radioligand binding data are means þ S.E.M. (n = 9).
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subtype is involved in mediating the remaining K2-recep-
tor agonist e¡ect in K2A-KO cortex, mouse strains lack-
ing K2A-, K2B-, or K2C-receptor subtypes were crossed to
generate mice lacking two receptor subtypes. At present,
mice lacking K2A- and K2C-receptors (K2AC-KO) are the
only viable animals lacking two K2-receptor subtypes
that could be generated (Hein et al., 1999). In these
mice, the inhibitory e¡ect of UK14,304 was abolished
(Fig. 2B) indicating that K2A- and K2C-receptors are
required for the presynaptic inhibitory feedback loop.
The K2B-subtype does not appear to be involved in this
process.
Similar to the K2-receptor agonist UK14,304, exoge-
nous norepinephrine was also able to inhibit transmitter
release in a concentration-dependent manner (Fig. 2C).
Compared with wild-type or K2C-KO cortex, inhibition
by norepinephrine was reduced in K2A-KO cortex and
absent in K2AC-KO tissues (Fig. 2C). In brain cortex
from K2B-KO mice, the inhibitory e¡ect of norepineph-
rine on transmitter release did not di¡er from wild-type
mice (Fig. 2C).
To test whether endogenous norepinephrine regulates
its own release via the same receptor subtypes, tissue
specimens were repeatedly stimulated with one to 64
electrical pulses to mimic autoinhibition conditions
(Fig. 3A). With increasing number of pulses, the amount
of transmitter released from K2A-KO tissues was signi¢-
cantly higher than from wild-type, K2B-KO or K2C-KO
Fig. 2. Inhibition of [3H]norepinephrine release in mouse brain
cortex slices from wild-type or K2-KO mice by the K2-receptor
agonist UK14,304. (A) Tritium e¥ux-versus-time curves from
brain cortex slices of wild-type mice. Cortex slices were stimulated
with single trains of four pulses at 100 Hz (arrow) at 20-min inter-
vals. In the absence of agonist, release of [3H]norepinephrine was
constant for ¢ve stimulation periods (upper trace), but was com-
pletely inhibited by addition of the K2-receptor agonist UK14,304
(lower trace). (B) Concentration^response curves for UK14,304.
Release of [3H]norepinephrine could be inhibited by UK14,304 in
cortex slices from wild-type mice or animals lacking single K2-
receptor subtypes. No agonist e¡ect was observed in tissues from
mice de¢cient in K2A- and K2C-receptor subtypes (K2AC-KO). (C)
Inhibition of norepinephrine release from mouse brain cortex by
exogenous norepinephrine. Inhibition of transmitter release did
not di¡er between wild-type, K2B-KO and K2C-KO tissues. How-
ever, the inhibitory e¡ect of norepinephrine was greatly reduced in
the K2A-de¢cient mice and was completely absent in mice lacking
K2A- and K2C-adrenergic receptors. Data are means þ S.E.M. from
8^16 tissue pieces.
Fig. 3. Autoinhibition of [3H]norepinephrine release by endoge-
nously released transmitter in brain cortex slices. (A) Representa-
tive tritium e¥ux-versus-time curve from brain cortex of wild-type
mice. After loading with [3H]norepinephrine, cortex slices were
stimulated with one, two, or 64 pulse trains at 1 Hz (four pulses
at 100 Hz per train). Blockade of K2-receptors with the non-sub-
type-selective antagonist rauwolscine (1 WM) increased release elic-
ited by 64 pulse trains signi¢cantly. (B) [3H]Norepinephrine release
in brain cortex from wild-type, K2A-KO, K2B-KO, K2C-KO, and
K2AC-KO mice (n = 8^16 tissue slices). Transmitter release was
signi¢cantly higher in specimens from K2A-KO or K2AC-KO
compared with wild-type mice (P6 0.05), indicating lack of pre-
synaptic K2-autoinhibition in these mice.
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tissues (Fig. 3B). In K2AC-KO cortex, norepinephrine
release was even higher than in K2A-de¢cient specimens
and reached the same magnitude as pharmacological in-
hibition of K2-receptors with the antagonist rauwolscine
(Fig. 3B). Thus, K2A- and K2C-receptors can both inhibit
release of endogenous norepinephrine under autoinhibi-
tion conditions.
K2-Heteroreceptors regulating dopamine release
Physiological and pharmacological experiments sug-
gest that K2-adrenergic receptors inhibit presynaptic
release of a number of other neurotransmitters, including
dopamine, serotonin and acetylcholine (Starke et al.,
1989). To determine whether K2-heteroreceptor subtypes
di¡er from the subtypes operating as autoreceptors,
release of [3H]dopamine was measured in small speci-
mens of basal ganglia from wild-type and K2-receptor-
de¢cient mice. When basal ganglia were preincubated
with [3H]dopamine, electrical stimulation with short
pulse trains elicited release of dopamine (Fig. 4A). The
amount of transmitter released by short pulse trains did
not di¡er between wild-type and K2-receptor-de¢cient
tissues. Uptake or release of [3H]dopamine was not
changed in the presence of the norepinephrine transport
inhibitor desipramine (data not shown). In non-trans-
genic basal ganglia, the K2-receptor agonist UK14,304
inhibited dopamine release in a concentration-dependent
manner by maximally 79% (Fig. 4A, B). The inhibitory
e¡ect of the K2-receptor agonist was not changed in K2B-
or K2C-receptor-de¢cient tissues when compared with
wild-type basal ganglia. However, K2-receptor-mediated
inhibition was greatly reduced in K2A-KO basal ganglia
and it was completely absent in specimens from K2AC-
KO mice (Fig. 4B). Thus, similar to the K2-autoreceptors
regulating norepinephrine release in the brain cortex,
dopamine release from basal ganglia is modulated by
the two receptor subtypes K2A and K2C.
Fig. 4. Inhibition of dopamine release from basal ganglia of wild-
type and K2-KO mice. Basal ganglion specimens were incubated
with [3H]dopamine and release of dopamine was elicited by single
electrical pulse trains. (A) Representative tritium e¥ux curves
from basal ganglia of wild-type mice. In the absence of K2-recep-
tor agonist, the amount of released transmitter remained constant
over four stimulation periods (upper trace), but it was completely
inhibited by addition of the K2-receptor agonist UK14,304 (lower
trace). (B) The K2-receptor agonist UK14,304 inhibited dopamine
release in basal ganglia from wild-type mice and mice lacking sin-
gle K2-receptor subtypes. The maximal inhibitory e¡ect of
UK14,304 was greatly reduced in K2A-KO mice, and there was no
agonist e¡ect in K2AC-KO mice. Data are means þ S.E.M. from
nine to 12 tissue slices per genotype.
Fig. 5. Time course of the onset of presynaptic inhibition of
[3H]norepinephrine release in mouse brain cortex by K2A- and
K2C-receptors. (A) Transmitter release was stimulated by one, two,
three, or four sequential electrical pulses (interval 1 s) in K2A-KO
and K2C-KO tissues. The magnitude of transmitter release during
the ¢rst, second, third and fourth pulse is indicated by the shaded
area. Data shown are from a representative experiment. (B) Time
course of the transmitter release per pulse from K2A-KO, K2C-KO
and K2AC-KO cortex. The time course of presynaptic inhibition
was determined at 1 Hz stimulation frequency. In tissues from
K2AC-KO mice, the amount of transmitter released during up to
31 sequential electrical pulse trains remained constant, indicating
the absence of presynaptic inhibition. In K2C-KO cortex, presynap-
tic inhibition was much faster than in K2A-KO tissue. Data are
means þ S.E.M. from four to eight experiments.
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Time course of feedback inhibition by K2A- and
K2C-receptors
To test whether K2A- and K2C-receptors are function-
ally di¡erent, the time course of the onset of presynaptic
inhibition of norepinephrine release in brain cortex was
determined. For this purpose, tissue slices were stimu-
lated with one to 31 single electrical pulses at 1 Hz and
release of transmitter during each pulse was calculated as
illustrated in Fig. 5A. To determine transmitter release
elicited by the n-th pulse, the amount of released trans-
mitter by (n31) pulses was subtracted from the amount
released by n pulses. With one or two electrical pulses,
norepinephrine release was similar for K2A-KO and K2C-
KO cortex (Fig. 5A). However, the amount of norepi-
nephrine released during the following pulses declined
much faster in K2C-KO tissues than in K2A-KO tissues.
Half-maximal inhibition occurred within 0.11 s in the
K2C-KO but required 1.97 s in K2A-KO (Fig. 5B). The
time course of inhibition did not depend on the stimula-
tion frequency as the half-times for inhibition did not
di¡er signi¢cantly between 3 Hz and 1 Hz (data not
shown). Transmitter release from K2AC-KO cortex did
not change between one and 31 pulses, indicating the
absence of endogenous autoinhibition. These results
demonstrate that the K2A-receptor system operates at
higher speed to inhibit transmitter release than the K2C-
subtype.
Desensitization of presynaptic K2-adrenergic receptors
In order to address whether presynaptic K2-receptors
are subject to desensitization upon prolonged stimula-
tion, tissues were incubated with 10 WM norepinephrine
for 30 min before the inhibitory e¡ect of the K2-receptor
agonist UK14,304 on transmitter release was determined
(Fig. 6). In brain cortex slices, no e¡ect of norepineph-
rine pretreatment on the inhibitory e¡ect of UK14,304
could be detected (data not shown). However, in isolated
mouse atria 30 min incubation with norepinephrine atte-
nuated the e¡ect of UK14,304 in specimens from K2A-
KO mice but not in tissues from wild-type mice or other
genotypes (Fig. 6).
DISCUSSION
These studies demonstrate that two K2-adrenergic
receptor subtypes operate as presynaptic inhibitory recep-
tors regulating transmitter release. Both K2A- and K2C-
receptor subtypes were found to inhibit norepinephrine
release in the brain cortex and dopamine release from
basal ganglia. Presynaptic inhibition by the K2A-receptor
subtype occurred signi¢cantly faster than signalling by
the K2C-receptor system. Upon prolonged exposure to
agonist, K2C-receptors were subject to desensitization.
Previous pharmacological experiments have identi¢ed
the K2A-adrenergic receptor as the principal inhibitory
autoreceptor in adrenergic neurons (Trendelenburg et
al., 1993). In gene-targeted mice lacking single K2-recep-
tor subtypes, presynaptic feedback inhibition was
reduced in tissues from K2A-KO mice (Altman et al.,
1999; Hein et al., 1999; Trendelenburg et al., 1999).
The presence of additional or other K2-receptor subtypes
was previously suggested based on experiments with
somewhat subtype-selective ligands (Ho et al., 1998).
However, due to the lack of su⁄ciently selective antag-
onists, it was impossible to identify unequivocally the
nature of the second subtype. By selective deletion of
the three K2-receptor subtypes in mice, the K2C-receptor
subtype could be identi¢ed as a second inhibitory pre-
synaptic receptor in sympathetic neurons (Hein et al.,
1999). However, previous experiments did not distin-
guish whether K2A- and K2C-receptors are present in
wild-type neurons, or whether up-regulation of one
receptor subtype compensates for loss of the other sub-
type in knockout mice.
Several lines of evidence suggest that K2A- and K2C-
receptors operate also in wild-type mice as integral
parts of the presynaptic feedback loop. Autoradiography
and radioligand binding experiments (Fig. 1) indicate
that both K2A- and K2C-receptors are present in normal
mouse brain, although K2C-receptors seem to be
expressed at 10-fold lower levels than K2A-receptors.
Experiments on peripheral tissues, e.g. heart atria, dem-
onstrate that the K2C-receptor subtype mediates autoin-
hibition by low concentrations of norepinephrine in wild-
type mice, whereas the potency of norepinephrine at the
K2A-receptor subtype was lower (Hein et al., 1999). This
potency di¡erence of norepinephrine for the K2-receptors
correlates with the a⁄nity di¡erence of norepinephrine
for the K2A- and K2C-receptor subtypes, respectively.
Furthermore, there is no evidence so far that the expres-
sion of the remaining K2-receptor subtypes is altered in
mice carrying deletions in K2A- or K2C-receptor genes
(Link et al., 1995; Altman et al., 1999). Our ¢ndings
con¢rm and extend the studies of Trendelenburg et al.,
2001, who have recently shown in several tissues that
inhibitory presynaptic regulation of norepinephrine
release is mediated by K2A- and K2C-receptors.
Fig. 6. Desensitization of presynaptic K2-adrenergic receptors in
sympathetic nerves after incubation with norepinephrine. Mouse
atria were incubated with [3H]norepinephrine followed by 30 min
incubation in the presence or absence of 10 WM norepinephrine.
Electrically induced release of [3H]norepinephrine was determined
in the presence of 1 WM UK14,304. After norepinephrine stimula-
tion, the inhibitory e¡ect of the K2-receptor agonist UK14,304 was
signi¢cantly attenuated in atria from K2A-KO mice, but not in tis-
sues from wild-type mice or animals lacking K2B- or K2C-receptors.
Data are means þ S.E.M. from six to seven experiments.
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Two K2-adrenergic receptor subtypes are also operat-
ing as heteroreceptors regulating dopamine release. Sim-
ilar to the situation in the brain cortex, K2A- and
K2C-receptors inhibited the release of dopamine from
mouse basal ganglia by exogenous K2-receptor agonists.
Previous studies using pharmacological ligands had
shown that the K2A-receptor subtype is the principal
K2-receptor subtype involved in the control of dopamine
exocytosis (Trendelenburg et al., 1994). Whereas the K2A-
receptor subtype shows a wide distribution in the brain,
the K2C-receptor is expressed at much lower densities and
is concentrated primarily in basal ganglia, olfactory cells
and hypothalamus (Nicholas et al., 1993, 1996; Scheinin
et al., 1994; MacDonald and Scheinin, 1995; Talley et
al., 1996; Tavares et al., 1996). Radioligand binding to
the K2C-receptor occurs in highest density in the stria-
tum, relative to other brain regions (Link et al., 1995).
However, the precise cellular localization of the K2C-
receptor subtype in basal ganglia is unknown at present.
Basal ganglia receive only a sparse innervation by nor-
adrenergic terminals and the total amount of norepi-
nephrine in basal ganglia is much lower than the
concentration of stored dopamine (Moore and Card,
1984). It has been demonstrated that activation of K2-
adrenergic receptors by dopamine inhibits adenylyl
cyclase in basal ganglia (Zhang et al., 1999), indicating
that K2-receptor stimulation by dopamine may contrib-
ute to presynaptic regulation of dopamine exocytosis.
Using gene targeting in mice, the role of dopamine D2
and D3 receptors in presynaptic regulation of dopamine
release has been recently investigated (Koeltzow et al.,
1998; L’hirondel et al., 1998). These mouse models are
essential tools to further evaluate the role of dopamine
and K2-adrenergic receptors in regulating endogenous
dopamine release. These studies extend the observation
that also serotonin release is controlled by these two K2-
adrenergic receptors (Scheibner et al., 2001).
The present studies do not show evidence for a speci¢c
role of the K2B-receptor subtype to regulate norepineph-
rine or dopamine release in the brain cortex or basal
ganglia, respectively. In total brain membrane fractions,
the abundance of K2B-receptors was too low for detec-
tion by radioligand binding (Fig. 1B). However, several
groups have reported that mRNA for the K2B-adrenergic
receptor was detectable in thalamic nuclei of the rat
brain (Nicholas et al., 1993, 1996; Scheinin et al.,
1994; MacDonald and Scheinin, 1995). Further studies
using knockout mice will have to show whether K2B-
receptors are involved in the regulation of neurotrans-
mitter release in the thalamus.
It is interesting to speculate about the physiological
relevance of the two presynaptic K2-receptor subtypes.
Inhibition by both subtypes may be physiologically rele-
vant as the time course of the onset of presynaptic inhi-
bition was di¡erent for the two subtypes. Inhibition of
norepinephrine release by the K2A-receptor was much
faster than inhibition by the K2C-receptor subtype. In
addition, experimental evidence was obtained that pre-
synaptic K2C-receptors are subject to agonist-dependent
desensitization (Fig. 6). In atria from mice lacking the
K2A-receptor subtype, stimulation with norepinephrine
attenuated the inhibitory e¡ect of an K2-receptor agonist
on transmitter release. No desensitization could be
observed in wild-type tissues or specimens from mice
lacking K2B- or K2C-receptors. Thus only under condi-
tions of decreased presynaptic receptor reserve (deletion
of the K2A-receptor subtype) could desensitization of pre-
synaptic receptors be detected. Interestingly, in vitro
studies have previously suggested that K2-receptor sub-
types are subject to di¡erential desensitization while
some reports have indicated that K2C-receptors cannot
be turned o¡ by homologous desensitization (Eason et
al., 1992; Eason and Liggett, 1992). However, the
present studies clearly indicate that signaling via neuro-
nal K2C-receptors is attenuated after prolonged agonist
exposure.
Thus, the presence of two inhibitory presynaptic recep-
tors may improve regulation of neurotransmission. Sev-
eral mechanisms may contribute to the observed
functional di¡erence between K2A- and K2C-receptors.
Di¡erent intracellular signalling pathways have been
identi¢ed by which G protein-coupled receptors can
inhibit transmitter release (Hille, 1994; Jeong and
Ikeda, 2000). Thus, these two K2-receptor subtypes may
be di¡erentially coupled to these pathways. Alternatively,
presynaptic K2-receptors may be targeted to speci¢c
domains of the presynaptic membrane. Indeed, all three
K2-adrenergic receptor subtypes show distinct intracellu-
lar distribution and agonist-induced tra⁄cking when
transfected cells in vitro (Daunt et al., 1997; Olli-Lahdes-
maki et al., 1999). These transgenic mice lacking individ-
ual K2-receptor subtypes will be instrumental to de¢ne
further the role of the K2A- and K2C-adrenergic receptors
in presynaptic regulation of adrenergic and dopaminergic
neurotransmission.
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